Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 3001 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Plus Therapeutics, Inc.

PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: PMV Pharmaceuticals, Inc.

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Aligos Therapeutics, Inc.

One Biosciences Welcomes Dr. Scott Braunstein and Dr. Vincent Miller to its Board of Directors

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: One Biosciences

Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: PharmAla Biotech

Vaxart to Present at World Vaccine Congress Washington 2024 on April 3

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Vaxart, Inc

89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: 89bio, Inc.

Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Immuneering Corporation

R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: R1 RCM

Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Avicanna Inc.

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Catalyst Pharmaceuticals, Inc.

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: AEterna Zentaris Inc.

Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: ASLAN Pharmaceuticals Ltd.

Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Adaptive Biotechnologies Corporation

CorMedix Inc. to Present at the Needham Annual Healthcare Conference

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: CorMedix Inc.

NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Lixte Biotechnology Holdings, Inc

Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Dyne Therapeutics, Inc.

Wave Life Sciences to Present at Upcoming Investor Conferences

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Wave Life Sciences USA, Inc.

Dyadic to Attend Industry Events in April

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Dyadic International, Inc.

Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Read more ››

By: GlobeNewswire - 27 Mar 2024

Related companies: Vaccinex, Inc

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑